Generic name: Dichlorphenamide 50mg
Dosage form: tablet
Medically reviewed on January 1, 2017.
Initiate dosing at 50 mg twice daily. The initial dose may be increased or decreased based on individual response, at weekly intervals (or sooner in case of adverse reaction). The maximum recommended total daily dose is 200 mg.
Primary hyperkalemic periodic paralysis, primary hypokalemic periodic paralysis, and related variants are a heterogeneous group of conditions, for which the response to KEVEYIS may vary. Therefore, prescribers should evaluate the patient's response to KEVEYIS after 2 months of treatment to decide whether KEVEYIS should be continued.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
More about Keveyis (dichlorphenamide)
- Keveyis Side Effects
- During Pregnancy
- Drug Interactions
- Pricing & Coupons
- En Español
- Drug class: carbonic anhydrase inhibitors
Other brands: Daranide